Will stop Serum's vehicles if doses not given to Maharashtra: Raju Shetti

He claimed people in Maharashtra are angry over not getting the vaccine, and many vaccination centres are closed due to the shortage of doses

Serum Institute, coronavirus vaccine
ANI General News
2 min read Last Updated : Apr 10 2021 | 4:14 PM IST

Following the Maharashtra government's claim about the state facing a shortage of Covid-19 vaccine, Swabhimani Shetkari Saghtana (SSS) leader Raju Shetti on Friday warned the Central government to increase the vaccine supply to the state within a week or his party will stop vehicles transporting vaccines to other states from Serum Institute of India (SII).

"I've written to Prime Minister, Home Minister and Health Minister stating that if the supply of vaccines is not increased for Maharashtra within a week, we will start stopping vehicles transporting vaccines to other states from Serum Institute of India," Shetti told media.

He claimed people in Maharashtra are angry over not getting the vaccine, and many vaccination centres are closed due to the shortage of doses.

"It is very unfortunate that they don't even understand that if more than half of the cases reported in the country are from Maharashtra then it must be given more vaccines... If our people are struggling to get the bed in Hospitals then Maharashtra is the state which needs to be provided vaccines on priority," the SSS leader said.

"Our stand is clear if we are not provided vaccines we will make sure that the vaccines manufactured in Maharashtra, manufactured in Pune in specifically, will not leave for other states," he added.

Maharashtra Health Minister Rajesh Tope on Thursday said the state is facing a COVID-19 vaccine crunch and demanded 40 lakh doses every week from the Centre. The state reported 58,993 new Covid-19 cases, 45,391 recoveries, and 301 deaths on Friday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineSerum Institute of India

First Published: Apr 10 2021 | 4:14 PM IST

Next Story